...
首页> 外文期刊>Medical mycology: official publication of the International Society for Human and Animal Mycology >In vitro activity of Caspofungin combined with Fluconazole on mixed Candida albicans and Candida glabrata biofilm
【24h】

In vitro activity of Caspofungin combined with Fluconazole on mixed Candida albicans and Candida glabrata biofilm

机译:Caspofungin的体外活性与氟康唑混合念珠菌混合念珠菌和Candida Glabrata Biofilm联合

获取原文
获取原文并翻译 | 示例
           

摘要

The objective of this study was to evaluate the antifungal effect of caspofungin (CAS) combined with fluconazole (FLU) on the biofilm biomass and cultivable viability and microstructure of Candida albicans and Candida glabrata mixed biofilm in vitro. Biofilms were formed in a 96-well microtiter plate for crystal violet assay and colony forming unit (CFU) method and grown on plastic coverslip disks for scanning electron microscopy. MIC50 of CAS and FLU against single Candida spp. and mixed Candida spp. biofilms were evaluated using crystal violet assay. Additional, C. albicans and C. glabrata mixed biofilms were incubated with subinhibitory CAS concentration plus FLU and their percentages of Candida biofilm reduction were calculated. We found that percentages of biofilm reduction were significantly decreased when CAS at 0.25MIC and FLU (0.25 or 0.5MIC) were combined (P < .05) but not different when CAS at 0.5 MIC combined with FLU at 0.25 or 0.5MIC, compared to CAS treatment alone. Structural analyses revealed that CAS/FLU combination-treated biofilms showed less hyphae and blastospores with some aberrant cells compared to control group. Although it was evident that a greater CFU of Candida glabrata were demonstrated in every group, the total viable cells derived from CAS/FLU combination-treated biofilms at any ratio were not significantly different from positive control. Overall, CAS/FLU combinations appeared to affect the quantity and cell architecture, but number of viable cell, of Candida albicans and Candida glabrata mixed biofilm. This antifungal effect was CAS concentration dependent.
机译:本研究的目的是评估Caspofungin(CAS)与氟康唑(流感)对生物膜生物质和念珠菌和念珠菌的微观结构以及体外念珠菌的耐候活力和微观结构的抗真菌效应。生物膜形成为晶体紫色测定和菌落形成单元(CFU)方法的96孔微量滴定板中,并在塑料盖玻片盘上生长,用于扫描电子显微镜。 CAS和流感的MIC50对抗单个念珠菌SPP。和混合念珠菌SPP。使用晶体紫度测定评估生物膜。另外,C. albicans和C.blabrata混合生物膜与水下速率加入流感孵育,并计算念珠菌含有念珠菌的百分比。我们发现,当CAS为0.25mic和Fly(0.25或0.5mic)时(P <0.25或0.5m),但在0.5 MIC的CAS加入0.25或0.5mic时,当CAS为0.25或0.5mic时,当CAS为0.25米或0.5mic)但与0.25或0.5米的流感不同时,生物膜减少百分比显着降低单独进行CAS处理。结构分析显示,与对照组相比,CAS / Fly组合处理的生物膜显示出较少的菌丝和囊孢子,其具有一些异常细胞。尽管很明显,每组中都证明了念珠菌甘草的较大CFU,但是从CAS / Flu组合处理的生物膜衍生的总活细胞与阳性对照没有显着差异。总体而言,CAS / FLU组合似乎影响了数量和细胞架构,但念珠菌和Candida Glabrata混合生物膜的可活细胞数量。这种抗真菌效应是CAS浓度依赖性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号